Biogen Idec, founded in 2003 after a merger between Biogen and Idec Pharmaceuticals, is a biotechnology company that manufactures drugs to treat diseases such as Multiple Sclerosis, AIDS and Cancer. They have manufacturing plants in Kendall Square, in Research Triangle Park, North Carolina and Hoofddorp, Netherlands.
Key Dates
- 2003: Biogen Idea is founded after merger between Biogen and Idec Pharmaceuticals
- 2003: Ground-breaking in Denmark for a manufacturing plant
- 2004: Construction completed San Diego Research and Corporate Campus
- 2005: Suspended production and distribution of Tysabri
- 2008: FDA approves Tysabri
Commercial Affiliates
Biogen Idec News and Info
References
Fast Facts
-
Stock symbol
NASDAQ: BIIB
-
Annual revenue (2007)
$2.26 billion US
-
Year Established
-
Industry
-
Phone
617-679-2000
-
Fax
617-679-2617
-
HQ
-
Fact:
President and CEO: James C. Mullen
-
Other key people
-
Staff
4,166
-
Products
